Johnson Craig A
SEC CIK 1370348 · EDGAR
BoughtSold
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 | |
| 2025-11-24 | 2025-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Johnson Craig A | Dir | F - Tax | $15.68 | -6,039 | 14.6K | -29% | -$94.7K | |
| DA | 2025-02-04 | 2025-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +17.9K | 83.8K | +27% | $0 |
| D | 2025-02-03 | 2025-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +17.9K | 83.8K | +27% | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Johnson Craig A | Dir | A - Grant | $0.00 | +20.6K | 20.6K | New | $0 |
| D | 2024-01-19 | 2024-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +13.9K | 65.8K | +27% | $0 |
| D | 2022-12-20 | 2022-12-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +38.6K | 51.9K | +290% | $0 |
| D | 2021-12-23 | 2021-12-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | S - Sale | $9.73 | -250 | 2,840 | -8% | -$2,432 |
| D | 2021-12-23 | 2021-12-22 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | A - Grant | $0.00 | +10.5K | 13.3K | +368% | $0 |
| 2021-09-23 | 2021-09-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Dir | S - Sale | $12.30 | -250 | 3,090 | -7% | -$3,075 |
Purchase Sale Sale after option exercise All abbreviations